AMPH Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Amphastar Pharmaceuticals, Inc

Watchlist Manager

Watchlist

Price: 24.7 USD -5.15% Market Closed

Market Cap: $1.1B

	Amphastar Pharmaceuticals, Inc NASDAQ:AMPH	US
	Schindler Holding AG SIX:SCHP	CH
S	Simat Technologies PCL SET:SIMAT	TH
N	Noontalk Media Ltd SGX:SEJ	SG
P	Pakuwon Jati Tbk PT IDX:PWON	ID
V	Vinyl Group Ltd ASX:VNL	AU
P	Pudo Inc CNSX:PDO	CA
I	Ionis Pharmaceuticals Inc XMUN:ISI	US
D	Darco Water Technologies Ltd SGX:BLR	SG
N	NICE Holdings Co Ltd KRX:034310	KR
	Monarch Casino & Resort Inc F:MOI	US
	Gruma SAB de CV OTC:GPAGF	MX

Profitability Summary

Amphastar Pharmaceuticals, Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

48%

Strong 3Y Average Gross Margin

51%

Declining Gross Margin

54% > 48%

Healthy Operating Margin

16%

Sustainable 3Y Average Operating Margin

25%

Declining Operating Margin

29% > 16%

Healthy Net Margin

11%

Sustainable 3Y Average Net Margin

18%

Declining Net Margin

22% > 11%

Exceptional Free Cash Flow Margin

21%

Strong 3Y Average Free Cash Flow Margin

20%

Declining Free Cash Flow Margin

23% > 21%

Positive ROE

10%

Positive 3Y Average ROE

Positive 3Y Average ROIC

12%

Declining ROIC

16% > 6%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.